Role of Resolvins in Inflammatory and Neuropathic Painopen access
- Authors
- Park, Jaeik; Roh, Jueun; Pan, Jingying; Kim, Yong Ho; Park, Chul-Kyu; Jo, Youn Yi
- Issue Date
- Oct-2023
- Publisher
- MDPI
- Keywords
- resolvin; inflammatory pain; neuropathic pain; inflammation; pain management; dorsal root ganglia; spinal cord
- Citation
- PHARMACEUTICALS, v.16, no.10
- Journal Title
- PHARMACEUTICALS
- Volume
- 16
- Number
- 10
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/90138
- DOI
- 10.3390/ph16101366
- ISSN
- 1424-8247
1424-8247
- Abstract
- Chronic pain is an unpleasant experience associated with actual or potential tissue damage. Inflammatory pain alerts the body to inflammation and promotes healing; however, unresolved inflammation can lead to chronic pain. Conversely, neuropathic pain, due to somatosensory damage, can be a disease in itself. However, inflammation plays a considerable role in the progression of both types of pain. Resolvins, derived from omega-3 fatty acids, actively suppress pro-inflammatory mediators and aid in the resolution of inflammation. Resolvins alleviate various inflammatory and neuropathic pain models by reducing hypersensitivity and regulating inflammatory cytokines and glial activation in the spinal cord and dorsal root ganglia. Thus, resolvins are a promising alternative for pain management with the potential to reduce the side effects associated with conventional medications. Continued research is crucial to unlock the therapeutic potential of resolvins and integrate them into effective clinical pain management strategies. This review aimed to evaluate the literature surrounding the resolvins in inflammatory and neuropathic pain.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - ETC > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/90138)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.